Saturday, April 11, 2020 6:37:42 PM
We DO NOT plan to reintroduce a reverse split later this year. As far as the dilution, we have no control of the market. That is not totally true, since we have been starving the old toxic lenders until we can raise the money within our new partners through the sale of their stock to help us to buy out our old toxic loans. We thought that the old lenders were out of stock while we raise the money; to our surprise, they managed to come up with almost 750K shares the last three days.
Some good signs was provided by our private IR group in that they advised me on Friday that they had information that our stock had over 300 million shorts. On Tuesday at mid-day, the shorts had been reduced to 79 million. I don't have an updated number at the moment, but it became clear that some of the shorts had been covered by the sale of some 600 million shares on Monday and Tuesday. At any rate, the dilution problem should be substantially reduced or eliminated by the buy-out of debt. That we plan to do ASAP.
William A. Hartman
President/CEO
Premier Biomedical, Inc.
Office: (814) 786-8849
Skype: w.a.hartman
www.premierbiomedical.com
www.painreliefmeds.com
Note: He gave me the ok to share.
______________________________________________________________________
My comments are based on personal opinions. Please do your own DD before you invest.
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM